PRECIGEN, INC. Income (Loss) from Equity Method Investments
PRECIGEN, INC. (PGEN) reported Income (Loss) from Equity Method Investments of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-19.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2025-03-19
- PRECIGEN, INC. income (loss) from equity method investments for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. income (loss) from equity method investments for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. income (loss) from equity method investments for the quarter ending 2023-06-30 was $0.00.
- PRECIGEN, INC. income (loss) from equity method investments for the quarter ending 2023-03-31 was $0.00.
- PRECIGEN, INC. income (loss) from equity method investments for fiscal 2024 was $0.00.
- PRECIGEN, INC. income (loss) from equity method investments for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- PRECIGEN, INC. income (loss) from equity method investments for fiscal 2022 was $862.00K.
- PRECIGEN, INC. income (loss) from equity method investments for fiscal 2021 was -$3.00K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-19 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $0.00 derived: sum of 2 quarters · filed 2025-03-19 | $0.00 derived: sum of 3 quarters · filed 2025-03-19 | $0.00 10-K · filed 2025-03-19 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $1.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $1.00K derived: sum of 3 quarters · filed 2025-03-19 | $863.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $1.00K derived: sum of 2 quarters · filed 2025-03-19 | $863.00K derived: sum of 3 quarters · filed 2025-03-19 | $863.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $863.00K derived: sum of 2 quarters · filed 2025-03-19 | $863.00K derived: sum of 3 quarters · filed 2025-03-19 | $862.00K 10-K · filed 2025-03-19 |
| 2022-09-30 | $862.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $862.00K derived: sum of 2 quarters · filed 2023-11-09 | $861.00K 10-Q · filed 2023-11-09 | $861.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.00K 10-Q · filed 2023-08-09 | -$1.00K derived: sum of 3 quarters · filed 2024-03-19 | -$1.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-03-31 | -$1.00K 10-Q · filed 2023-05-10 | -$1.00K derived: sum of 2 quarters · filed 2024-03-19 | -$1.00K derived: sum of 3 quarters · filed 2024-03-19 | -$1.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $0.00 derived: sum of 2 quarters · filed 2024-03-19 | $0.00 derived: sum of 3 quarters · filed 2024-03-19 | -$3.00K 10-K · filed 2024-03-19 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | -$3.00K 10-Q · filed 2022-11-09 | -$16.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$3.00K 10-Q · filed 2022-08-08 | -$16.00K derived: sum of 3 quarters · filed 2023-03-06 | -$539.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | -$3.00K 10-Q · filed 2022-05-09 | -$16.00K derived: sum of 2 quarters · filed 2023-03-06 | -$539.00K derived: sum of 3 quarters · filed 2023-03-06 | -$790.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$536.00K derived: sum of 2 quarters · filed 2023-03-06 | -$787.00K derived: sum of 3 quarters · filed 2023-03-06 | -$1.18M 10-K · filed 2023-03-06 |
| 2020-09-30 | -$523.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$774.00K derived: sum of 2 quarters · filed 2021-11-08 | -$1.16M 10-Q · filed 2021-11-08 | -$2.86M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$251.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$640.00K 10-Q · filed 2021-08-09 | -$2.34M derived: sum of 3 quarters · filed 2022-03-01 | -$3.98M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$389.00K 10-Q · filed 2021-05-10 | -$2.08M derived: sum of 2 quarters · filed 2022-03-01 | -$3.73M derived: sum of 3 quarters · filed 2022-03-01 | -$5.48M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$3.34M derived: sum of 2 quarters · filed 2022-03-01 | -$5.09M derived: sum of 3 quarters · filed 2022-03-01 | -$6.73M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$1.65M 10-Q · filed 2019-11-12 | -$3.39M derived: sum of 2 quarters · filed 2019-11-12 | -$5.03M 10-Q · filed 2020-11-09 | -$6.76M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$1.75M 10-Q · filed 2019-08-09 | -$3.39M 10-Q · filed 2020-08-10 | -$5.12M derived: sum of 3 quarters · filed 2021-03-01 | -$7.99M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$1.64M 10-Q · filed 2020-05-11 | -$3.37M derived: sum of 2 quarters · filed 2021-03-01 | -$6.24M derived: sum of 3 quarters · filed 2021-03-01 | -$10.79M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$4.60M derived: sum of 2 quarters · filed 2021-03-01 | -$9.15M derived: sum of 3 quarters · filed 2021-03-01 | -$11.61M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$2.87M 10-Q · filed 2019-11-12 | -$7.42M derived: sum of 2 quarters · filed 2019-11-12 | -$9.88M 10-Q · filed 2019-11-12 | -$12.89M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$4.55M 10-Q · filed 2019-08-09 | -$7.01M 10-Q · filed 2019-08-09 | -$10.02M derived: sum of 3 quarters · filed 2020-03-02 | -$13.01M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$2.46M 10-Q · filed 2019-05-09 | -$5.47M derived: sum of 2 quarters · filed 2020-03-02 | -$8.46M derived: sum of 3 quarters · filed 2020-03-02 | -$11.80M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$6.00M derived: sum of 2 quarters · filed 2020-03-02 | -$9.34M derived: sum of 3 quarters · filed 2020-03-02 | -$14.28M 10-K · filed 2020-03-02 |
| 2017-09-30 | -$2.99M 10-Q · filed 2018-11-08 | -$6.33M derived: sum of 2 quarters · filed 2018-11-08 | -$11.27M 10-Q · filed 2018-11-08 | -$15.44M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$3.33M 10-Q · filed 2018-08-13 | -$8.28M 10-Q · filed 2018-08-13 | -$12.45M derived: sum of 3 quarters · filed 2019-03-01 | -$18.70M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$4.95M 10-Q/A · filed 2018-08-13 | -$9.12M derived: sum of 2 quarters · filed 2019-03-01 | -$15.37M derived: sum of 3 quarters · filed 2019-03-01 | -$20.42M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$10.42M derived: sum of 2 quarters · filed 2019-03-01 | -$15.48M derived: sum of 3 quarters · filed 2019-03-01 | -$21.12M 10-K · filed 2019-03-01 |
| 2016-09-30 | -$6.25M 10-Q · filed 2017-11-09 | -$11.31M derived: sum of 2 quarters · filed 2017-11-09 | -$16.95M 10-Q · filed 2017-11-09 | -$19.33M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | -$5.05M 10-Q · filed 2017-08-09 | -$10.70M 10-Q · filed 2017-08-09 | -$13.07M derived: sum of 3 quarters · filed 2018-03-01 | -$15.50M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | -$5.64M 10-Q · filed 2017-05-10 | -$8.02M derived: sum of 2 quarters · filed 2018-03-01 | -$10.45M derived: sum of 3 quarters · filed 2018-03-01 | -$12.63M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$4.81M derived: sum of 2 quarters · filed 2018-03-01 | -$6.99M derived: sum of 3 quarters · filed 2018-03-01 | -$8.94M 10-K · filed 2018-03-01 |
| 2015-09-30 | -$2.43M 10-Q · filed 2016-11-09 | -$4.61M derived: sum of 2 quarters · filed 2016-11-09 | -$6.57M 10-Q · filed 2016-11-09 | -$8.31M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$2.18M 10-Q · filed 2016-08-09 | -$4.14M 10-Q · filed 2016-08-09 | -$5.89M derived: sum of 3 quarters · filed 2017-03-01 | -$7.50M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$1.96M 10-Q · filed 2016-05-10 | -$3.71M derived: sum of 2 quarters · filed 2017-03-01 | -$5.33M derived: sum of 3 quarters · filed 2017-03-01 | -$6.68M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$3.37M derived: sum of 2 quarters · filed 2017-03-01 | -$4.72M derived: sum of 3 quarters · filed 2017-03-01 | -$5.26M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$1.62M 10-Q · filed 2015-11-09 | -$2.97M derived: sum of 2 quarters · filed 2015-11-09 | -$3.51M 10-Q · filed 2015-11-09 | -$3.73M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$1.35M 10-Q · filed 2015-08-10 | -$1.89M 10-Q · filed 2015-08-10 | -$2.11M derived: sum of 3 quarters · filed 2016-02-29 | -$2.11M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$536.00K 10-Q · filed 2015-05-11 | -$752.00K derived: sum of 2 quarters · filed 2016-02-29 | -$752.00K derived: sum of 3 quarters · filed 2016-02-29 | -$752.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$216.00K derived: sum of 2 quarters · filed 2016-02-29 | -$216.00K derived: sum of 3 quarters · filed 2016-02-29 | -$606.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | -$390.00K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$390.00K 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$390.00K 10-Q · filed 2014-05-09 | |||
| 2012-12-31 | -$274.00K 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |